Skip to main navigation Skip to search Skip to main content

Nutrients and Drugs in Alzheimer’s Disease: Harnessing Antioxidants

  • Malka Shteinberg
  • , Tehila Nissim
  • , Karin Ben Zaken
  • , Ibrahim O. Sawaid
  • , Lior Segev
  • , Samuel Mesfin
  • , Pnina Frankel
  • , Rahaf Ezzy
  • , Trishna Saha Detroja
  • , Naamah Bloch
  • , Baruh Polis
  • , Abraham O. Samson
  • Bar-Ilan University
  • University of Toronto

Research output: Contribution to journalReview articlepeer-review

Abstract

Alzheimer’s disease (AD) has been associated with various types of food and drugs. First, we review the nutrients commonly associated with AD in the literature. Then, we query PubMed citations for the co-occurrence of AD with foods and drugs, using a list of 217,776 molecules. Significantly, AD is found to be associated with prescription drugs, potential therapies, diagnostic agents of amyloid β (Aβ) and tau, potential biomarkers, inducers of AD in animal models, as well as drug scaffold moieties. Prescription drugs include rivastigmine (70.7%), donepezil (67.9%), galantamine (56.5%), tacrine (55.8%), physostigmine (6.5%), memantine (46.2%), selegiline (8.8%), and flurbiprofen (4.5%). Potential therapies include docosahexaenoic acid (3.5%), curcumin (4.6%), rosmarinic acid (3.6%), epigallocatechin (3.1%), resveratrol (3.3%), choline (4.5%), D-serine (4.4%), and D-aspartic acid (4.0%). Diagnostic agents include flortaucipir (39.5%) and exametazime (8.8%). Potential biomarkers include Aβ (81.1%), 24-hydroxycholesterol (38.1%), hydroxynonenal (6.2%), homocysteine (3.7%), and 3-nitrotyrosine (3.0%). Disease inducers include scopolamine (9.3%), mecamylamine (3.2%), α-bungarotoxin (3.0%), ibotenic acid (6.4%), okadaic acid (5.5%), quinolinic acid (4.9%), and streptozocin (3.8%). Drug scaffolds include aniline (5.1%), piperidine (4.9%), stilbene (3.9%), and benzofurane (3.0%). Notably, we classify the molecules according to their role in AD. Our study emphasizes the nutritional value of antioxidants, choline, D-serine, and D-aspartic acid in the prevention of AD. Furthermore, our study promulgates vitamin B, which lowers high homocysteine levels associated with dementia. This study is important because it shows how the foods we eat and the medicines we take influence the risk and progression of AD. By scanning huge amounts of medical research, we identified nutrients (like plant compounds such as those in green tea and turmeric) that help protect the brain, as well as drugs that can be repurposed for treatment. Since Alzheimer’s has no cure and is becoming more common worldwide, these findings highlight that diet, together with smarter drug use, can play a big role in preventing or slowing the disease.

Original languageEnglish
Pages (from-to)359-367
Number of pages9
JournalInternational Journal of Nutrition, Pharmacology, Neurological Diseases
Volume15
Issue number4
DOIs
StatePublished - 1 Oct 2025

Bibliographical note

Publisher Copyright:
© 2025 International Journal of Nutrition, Pharmacology, Neurological Diseases.

Keywords

  • Alzheimer’s disease
  • antioxidants
  • choline
  • curcumin
  • docosahexaenoic acid
  • epigallocatechin
  • resveratrol
  • rosmarinic acid

Fingerprint

Dive into the research topics of 'Nutrients and Drugs in Alzheimer’s Disease: Harnessing Antioxidants'. Together they form a unique fingerprint.

Cite this